Tip : |
časopis |
|
raziskovalne skupine : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
Avtor : |
Ensom MHH, Decarie D, Sheppard I. |
Naslov : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
Référence : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
Raven dokazov : |
|
Fizikalna stabilnost : |
|
Kemična stabilnost : |
|
Druge metode : |
|
Komentarji : |
|
Seznami
Lansoprazole
|
![Zaviralec protonske črpalke Zaviralec protonske črpalke](./images/Picto.504.jpg) |
![Stabilnost raztopine Stabilnost raztopine](./images/Picto.591.jpg) |
![Steklo Steklo](./images/Picto.532.jpg) |
![Kapsule Kapsule](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
25°C |
![Svetloba Svetloba](./images/Picto.528.gif) |
91 |
![Dan Dan](./images/Picto.542.gif) |
|
|
![Stabilnost raztopine Stabilnost raztopine](./images/Picto.591.jpg) |
![Steklo Steklo](./images/Picto.532.jpg) |
![Kapsule Kapsule](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
25°C |
![Svetloba Svetloba](./images/Picto.528.gif) |
91 |
![Dan Dan](./images/Picto.542.gif) |
|
|
![Stabilnost raztopine Stabilnost raztopine](./images/Picto.591.jpg) |
![Steklo Steklo](./images/Picto.532.jpg) |
![Kapsule Kapsule](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
4°C |
![Zaščiteno pred svetlobo Zaščiteno pred svetlobo](./images/Picto.526.jpg) |
91 |
![Dan Dan](./images/Picto.542.gif) |
|
|
![Stabilnost raztopine Stabilnost raztopine](./images/Picto.591.jpg) |
![Steklo Steklo](./images/Picto.532.jpg) |
![Kapsule Kapsule](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
4°C |
![Zaščiteno pred svetlobo Zaščiteno pred svetlobo](./images/Picto.526.jpg) |
91 |
![Dan Dan](./images/Picto.542.gif) |
|
|
|
|